Chrysalyne Schmults, MD, on Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma: Treatment Pipeline

Posted: Monday, April 1, 2019

Chrysalyne Schmults, MD, of Brigham and Women’s Hospital, discusses the recent approval of cemiplimab, similar agents in the pipeline, and other classes of drugs under study to treat metastatic or locally advanced cutaneous squamous cell cancer.